Rajput Rajesh, Chatterjee Sumanto, Rajput Meena
Department of Medicine VII & Endocrinology, Postgraduate Institute of Medical Sciences, Rohtak, Haryana 124001, India.
J Thyroid Res. 2011;2011:505239. doi: 10.4061/2011/505239. Epub 2011 Jul 14.
152 drug naïve primary hypothyroid patients were divided into morning (Group 1) and evening (Group 2) dosing group and evaluated for change in biochemical profile, physical functioning and Quality of Life during the course of 12 weeks of study. At the end of 12 weeks 70 (90.90%) subjects in Group 1 and 72 (96%) in Group 2 achieved euthyroidism. On evaluation clinical symptoms and total clinical scores improved in both the groups at the end of 6 and 12 weeks. Significant improvement in thyroid profile was seen in both the groups at the end of 6 and 12 weeks (P value <.0001). On intergroup comparison, no significant difference in thyroid profile was seen at 6 and 12 weeks between the morning and the evening dose group. Similar dose of levothyroxine was required to achieve euthyroidism in both the groups. Though an early restoration of euthyroidism was seen in evening group, the difference when compared to the morning group was not statistically significant. On assessment of QoL, statistically significant improvement in various parameters was seen in both the groups. Hence, from the study we inferred that evening dose is as efficacious as morning dose and provides an alternate dosing regimen.
152例初治原发性甲状腺功能减退患者被分为晨起服药组(第1组)和晚间服药组(第2组),并在为期12周的研究过程中对生化指标变化、身体功能和生活质量进行评估。12周结束时,第1组70例(90.90%)受试者和第2组72例(96%)受试者实现甲状腺功能正常。评估显示,两组在6周和12周结束时临床症状和总临床评分均有所改善。两组在6周和12周结束时甲状腺指标均有显著改善(P值<0.0001)。组间比较显示,晨起服药组和晚间服药组在6周和12周时甲状腺指标无显著差异。两组达到甲状腺功能正常所需的左甲状腺素剂量相似。虽然晚间服药组甲状腺功能正常恢复较早,但与晨起服药组相比差异无统计学意义。在生活质量评估中,两组各项参数均有统计学意义的改善。因此,从该研究中我们推断,晚间服药与晨起服药疗效相同,可提供另一种给药方案。